TNFSF14 and atopic eczema: Additionally, mice treated with anti-HVEM antibody (which neutralized LIGHT–HVEM but not LIGHT–LTβR; the antibody was administered every other day until the end of the experiment) had a markedly abrogated SCORAD (Severity Scoring of Atopic Dermatitis) index, strongly decreased epidermal thickening, and moderate albeit significant reduction in dermal thickness (110).